West Syndrome Market Insights 2017-2030: Epidemiology, Drugs, Players, Forecasts – GlobeNewswire

Dublin, July 09, 2020 (GLOBE NEWSWIRE) — The “West Syndrome – Market Insights, Epidemiology and Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.The total diagnosed prevalent population of West Syndrome in the 7 major markets was found to be 8,057 in 2017.In the United States, the diagnosed prevalent cases of West Syndrome was found to be 3,999 in 2017.The publisher has also analyzed gender-specific data for West Syndrome, which clearly suggests that it is more prevalent among males than females. It was found that in the United States the number of cases of West Syndrome in males and females were 2,399 and 1,600 respectively in 2017.In the EU5 countries the diagnosed prevalence of West Syndrome was found to be maximum in France with 737 cases, followed by the United Kingdom with 684 cases in 2017. While, the least number of cases were found in Spain, with 445 cases in 2017.In Japan, the diagnosed prevalence of West Syndrome was found to be 1,090 in 2017.Country-wise EpidemiologyThe market size of West Syndrome in the seven major markets was estimated to be USD 171.1 Million in 2017.The current treatment of West Syndrome is mainly dominated by the use of Hormonal Therapy (Acthar Gel Injection; Corticotropin), Vigabatrin – Anti-epileptic drugs (AEDs), Corticosteroids and Other off-label therapies.The United States accounts for the largest market size of West Syndrome, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.Among the EU5 countries, France had the highest market size with USD 9.76 Million in 2017, while Spain had the lowest market size of West Syndrome with USD 5.89 Million in 2017.The Japanese West Syndrome market accounted for USD 14.43 Million in 2017.Drugs UptakeThe report covers the descriptive overview of West Syndrome, explaining its causes, signs and symptoms, pathogenesis and currently available therapies.Comprehensive insight has been provided into the West Syndrome epidemiology and treatment.Additionally, an all-inclusive account of both the current and emerging therapies for West Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.A detailed review of West Syndrome market; historical and forecasted is included in the report, covering the 7MM drug outreach.The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM West Syndrome market.For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/op4ckResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Source: https://www.globenewswire.com/news-release/2020/07/09/2059874/0/en/West-Syndrome-Market-Insights-2017-2030-Epidemiology-Drugs-Players-Forecasts.html


Recommended


What is CBD Oil

CBD Benefits

cbd oil effects